A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on......
Private life insurers experienced reasonable growth in the July-September quarter (second quarter, or Q2) of 2023-24 (FY24), and the October data is also encouraging. Illustration: Uttam......
Private players continued to show strong momentum in the life insurance individual new business segment during August, 2023. Illustration: Uttam Ghosh/Rediff.com On an aggregate, the industry......
'If through growth and serving the customer we become number one, we will be very happy and very proud.' Illustration: Uttam Ghosh/Rediff.com Anup Bagchi, who took charge as managing director and......
At the end of June, the assets under management in the flexi-cap segment stood at Rs 1.76 trillion, the second highest after the large-cap category. Illustration: Dominic Xavier/Rediff.com The......
The life insurer tinkered with its business strategy — raised the share of protection plans and reduced dependency on ULIPs in the past four years. It’s rare for a firm to constantly......